Drug Manufacturers

Fluorescence Intensity Transcreener® assay used to detect ADP on the CLARIOstar®

By BMG LABTECH

The Transcreener ADP fluorescent intensity (FI) Assay from BellBrook Labs results in a fluorescent intensity output that can be used to quantify enzyme activity.

Any enzyme reaction that creates ADP as a byproduct can be monitored that way, allowing determining activities of e.g. protein, lipid, and carbohydrate kinases, ATPases, DNA helicases, carboxylases and glutamine synthetase.

The Transcreener ADP2 Assay is a simple one-step homogenous detection assay and is flexible with regard to ATP concentration (0.1μM to 100μM ATP). The assay was performed on the CLARIOstar multimode microplate reader from BMG LABTECH.

Download to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sections

Sections

Sections

Sections

Sections